Cervical cancer could be eliminated in Australia within the next 2 decades because of a free government program to vaccinate children against the human papillomavirus; employers have slowed enrollment in high-deductible health plans amid a very tight labor market and a postponement of a tax on healthcare coverage; President Barack Obama’s 2010 healthcare law is threatening Republicans in the midterms who have spent years railing against it and seeking its repeal.
Cervical cancer could be eliminated in Australia within the next 2 decades because of a free government program to vaccinate children against the human papillomavirus, The New York Times reported. By 2028, fewer than 4 women in every 100,000 could be diagnosed with cervical cancer annually in Australia, according to a study in The Lancet Public Health, and by 2066, fewer than 1 woman per year could receive that diagnosis. The vaccination program was implemented in schools nationwide.
Employers have slowed enrollment in high-deductible health plans amid a very tight labor market and a postponement of a tax on healthcare coverage, according to Kaiser Health News. In some cases, companies have reinstated more traditional plans as a strong job market gives workers more leverage. A return to more generous healthcare coverage is unlikely, however.
President Barack Obama’s 2010 healthcare law is threatening Republicans in the midterms who have spent years railing against it and seeking its repeal, The Washington Post reported. Some are scrambling to demonstrate they support one of the law’s most popular features—protections from discrimination based on pre-existing health conditions—when they are also actively continuing to support efforts to repeal the Affordable Care Act.
Allergies and Asthma Prevalence Rise With Climate Change Extremes and Pollutants
June 30th 2025Increasing environmental events driven by climate change and human activity exacerbate allergy and asthma conditions, further compounded by exposure to persistent pollutants like per-and polyfluoroalkyl substances and microplastics.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
MRD-Guided Ibrutinib Plus Venetoclax Effective in R/R CLL
June 30th 2025Patients with relapsed or refractory chronic lymphocytic leukemia (R/R CLL) had similar results when they continued on ibrutinib or stopped and started ibrutinib plus venetoclax based on minimal residual disease (MRD) status.
Read More